ESC 365 - TAVI for patients with congenital heart disease: a reasonable option?

ESC Premium Access

TAVI for patients with congenital heart disease: a reasonable option?

Session: Interventional treatment of valve disease in congenital heart disease patients

Topic: Intervention

Speaker: Professor L. Sondergaard (Copenhagen, DK)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Lars Sondergaard

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

15 presentations

2 followers

3 more presentations in this session

Valve disease in congenital heart disease - a growing problem.

Speaker: Doctor M. Ladouceur (Geneva, CH)

Pulmonary valve intervention: current experience and future perspectives.

Speaker: Professor A. Eicken (Munich, DE)

Panel discussion.

Access the full session

Interventional treatment of valve disease in congenital heart disease patients

Speakers: Professor L. Sondergaard, Doctor M. Ladouceur, Professor A. Eicken

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources